Ibrutinib-Related Atrial Fibrillation: An Anticoagulant Challenge.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 2, p. 47
- By:
- Publication type:
- Article
Works matching IS 21641153 AND DT 2019 AND VI 9 AND IP 2
Results: 6
1
2
Blinatumomab: A Step Forward in the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 2, p. 38
- By:
- Publication type:
- Article
3
HOPA Encourages Oncology Pharmacists to Deliver Patient Outreach Services.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 2, p. 36
- By:
- Publication type:
- Article
4
New Formulation of Bendamustine Associated with Phlebitis: Report of 2 Unique Patient Cases.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 2, p. 32
- By:
- Publication type:
- Article
5
Evaluation of Tbo-Filgrastim Use in Adults with Cancer at a Large Community Teaching Hospital.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 2, p. 24
- By:
- Publication type:
- Article
6
Chart Review of Predisposing Factors to Cisplatin-Induced Nephrotoxicity in Patients with Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 2, p. 11
- By:
- Publication type:
- Article